Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Supporters often stress the opportunity for substantial therapeutic gains, principally in diseases where conventional medications have proven inadequate. However, it's to evaluate the substantial financial burden associated with CPI stem cell therapy